Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
We should be seeking knowledge and guidance
Endocrinology and Metabolism, 289 (6), E1015E1022
Glucagon-like peptide 1 (glp-1)
Resistance of Hodgkins disease cell lines to TRAIL is independent of its receptor expression, cFLIP, and NF-kB
First, for generalizability to real-world practice, we identified a real-world representative cohort of T2D patients who were GLP-1RA and insulin users in the analyses and implemented a rigorous matching algorithm to match on a range of baseline patient characteristics (demographics, comorbidities, diabetes severity, concurrent medications) to achieve a greater level of between-group comparability
Interestingly, cellular complexity and size, as estimated by side scatter (SSC) and forward scatter (FSC) respectively, both were increased as a result of 18 h Exendin-4 pre-treatment, but not after 30 minutes of exposure (Fig
